Tozinameran (Croatian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Tozinameran" in Croatian language version.

refsWebsite

Global rank Croatian rank

45web.archive.org

1^st place

15nih.gov

4^th place

13^th place

12doi.org

2^nd place

12^th place

6reuters.com

49^th place

93^rd place

5bloomberg.com

99^th place

442^nd place

4fda.gov

447^th place

2,517^th place

4europa.eu

68^th place

35^th place

3gov.uk

432^nd place

3,805^th place

3theguardian.com

12^th place

42^nd place

3biontech.de

low place

3semanticscholar.org

11^th place

532^nd place

3washingtonpost.com

34^th place

200^th place

3cdc.gov

218^th place

226^th place

3canada.ca

1,712^th place

low place

2who.int

195^th place

132^nd place

2bbc.com

20^th place

34^th place

2cvdvaccine-us.com

low place

2aljazeera.com

268^th place

382^nd place

2mednet-communities.net

low place

2apnews.com

129^th place

577^th place

2nytimes.com

7^th place

28^th place

2admin.ch

279^th place

922^nd place

2scmp.com

362^nd place

3,137^th place

2yahoo.com

38^th place

162^nd place

1letemps.ch

1,980^th place

low place

1npr.org

92^nd place

781^st place

1statnews.com

8,771^st place

low place

1nbcnews.com

137^th place

377^th place

1nice.org.uk

3,258^th place

3,000^th place

1nhs.uk

1,989^th place

4,637^th place

1alarabiya.net

598^th place

1,426^th place

1gulfnews.com

765^th place

2,183^rd place

1gatesnotes.com

low place

1nejm.org

2,374^th place

3,285^th place

1degruyter.com

1,425^th place

738^th place

1biospectrumasia.com

low place

1worldcat.org

5^th place

8^th place

1swr.de

1,755^th place

low place

1eib.org

7,951^st place

low place

1axios.com

1,716^th place

8,090^th place

1europeanpharmaceuticalreview.com

low place

1bbc.co.uk

8^th place

19^th place

1england.nhs.uk

low place

1lanacion.com.ar

291^st place

8,102^nd place

1elpais.com

84^th place

1,325^th place

1france24.com

481^st place

1,413^th place

1arab.news

6,427^th place

low place

1msn.com

117^th place

247^th place

1jpost.com

544^th place

717^th place

1emirateswoman.com

low place

1newsd.in

low place

1luzernerzeitung.ch

8,534^th place

low place

1heidi.news

low place

1wired.com

193^rd place

374^th place

1gponline.com

low place

1healthycanadians.gc.ca

low place

1theglobeandmail.com

293^rd place

1,745^th place

1acs.org

1,248^th place

2,676^th place

1hhs.gov

5,973^rd place

low place

1cnn.com

28^th place

80^th place

1japantimes.co.jp

389^th place

1,861^st place

1cbc.ca

115^th place

658^th place

1gob.mx

3,255^th place

low place

1aifa.gov.it

low place

1telegraph.co.uk

30^th place

113^th place

1fortune.com

433^rd place

1,894^th place

1jakartaglobe.id

low place

acs.org

cen.acs.org

Mullin R. 25. studenoga 2020. Pfizer, Moderna ready vaccine manufacturing networks. Chemical & Engineering News. American Chemical Society. Washington, D.C.. Pristupljeno 21. prosinca 2020.

admin.ch

bag.admin.ch

Swissmedic grants authorisation for the first COVID-19 vaccine in Switzerland (priopćenje). Swiss Agency for Therapeutic Products (Swissmedic). 19. prosinca 2020. Pristupljeno 19. prosinca 2020.
COVID-19: Switzerland can start vaccinating vulnerable groups already in December (priopćenje). Federal Office of Public Health. 19. prosinca 2020. Pristupljeno 19. prosinca 2020.

aifa.gov.it

AIFA, possibile ottenere almeno 6 dosi da ogni flaconcino del vaccino BioNTech/Pfizer. aifa.gov.it (talijanski). Pristupljeno 29. prosinca 2020.

alarabiya.net

english.alarabiya.net

Bahrain becomes second country to approve Pfizer COVID-19 vaccine. Al Jazeera. Inačica izvorne stranice arhivirana 4. prosinca 2020. Pristupljeno 5. prosinca 2020.
- Coronavirus: Saudi Arabia approves Pfizer COVID-19 vaccine for use. Al Arabiya English. 10. prosinca 2020. Inačica izvorne stranice arhivirana 11. prosinca 2020. Pristupljeno 10. prosinca 2020.

aljazeera.com

Bahrain becomes second country to approve Pfizer COVID-19 vaccine. Al Jazeera. Inačica izvorne stranice arhivirana 4. prosinca 2020. Pristupljeno 5. prosinca 2020.
- Coronavirus: Saudi Arabia approves Pfizer COVID-19 vaccine for use. Al Arabiya English. 10. prosinca 2020. Inačica izvorne stranice arhivirana 11. prosinca 2020. Pristupljeno 10. prosinca 2020.
- Bahrain becomes second country to approve Pfizer COVID-19 vaccine. Al Jazeera. Pristupljeno 5. prosinca 2020.

apnews.com

Neergaard L, Kirka D. 2. prosinca 2020. Britain OKs Pfizer vaccine and will begin shots within days. AP. Inačica izvorne stranice arhivirana 6. prosinca 2020. Pristupljeno 6. prosinca 2020.
Singapore approves use of Pfizer's COVID-19 vaccine. AP News. 14. prosinca 2020. Pristupljeno 15. prosinca 2020.

arab.news

Kuwait authorizes emergency use of Pfizer-BioNTech COVID-19 vaccine. Arab News. 13. prosinca 2020. Pristupljeno 15. prosinca 2020.

axios.com

Pfizer CEO says he would've released vaccine data before election if possible. Axios. 9. studenoga 2020. Inačica izvorne stranice arhivirana 10. studenoga 2020. Pristupljeno 11. studenoga 2020.

bbc.co.uk

First patient receives Pfizer Covid-19 vaccine. 8. prosinca 2020. Inačica izvorne stranice arhivirana 8. prosinca 2020. Pristupljeno 8. prosinca 2020. Prenosi www.bbc.co.uk

bbc.com

Gallagher J. 9. studenoga 2020. Covid vaccine: First 'milestone' vaccine offers 90% protection. BBC News. Inačica izvorne stranice arhivirana 26. studenoga 2020. Pristupljeno 9. studenoga 2020.
Roberts M. 2. prosinca 2020. Covid Pfizer vaccine approved for use next week in UK. BBC News Online. Inačica izvorne stranice arhivirana 2. prosinca 2020. Pristupljeno 2. prosinca 2020.

biontech.de

investors.biontech.de

Pfizer and BioNTech Celebrate Historic First Authorization in the U.S. of Vaccine to Prevent COVID-19. Pfizer Inc. and BioNTech SE. Inačica izvorne stranice arhivirana 28. ožujka 2021. Pristupljeno 5. siječnja 2021.
Update on our COVID-19 vaccine development program with BNT162b2 (priopćenje). BioNTech. 2. prosinca 2020. Inačica izvorne stranice (PDF) arhivirana 3. prosinca 2020. Pristupljeno 12. prosinca 2020.
BioNTech and Fosun Pharma to Supply China with mRNA-based COVID-19 Vaccine (priopćenje). BioNTech. 16. prosinca 2020. Inačica izvorne stranice arhivirana 16. prosinca 2020. Pristupljeno 16. prosinca 2020.

biospectrumasia.com

CEPI's collaborative task force to assess COVID-19 vaccines on emerging viral strains. BioSpectrum - Asia Edition. 23. studenoga 2020. the first SARS-CoV-2 viral genomes were shared via GISAID on 10 January 2020

bloomberg.com

Deep-freeze hurdle makes Pfizer's vaccine one for the rich. Bloomberg. 10. studenoga 2020. Inačica izvorne stranice arhivirana 22. studenoga 2020. Pristupljeno 12. studenoga 2020.. Vaccine goes bad five days after thawing, requires two shots; Many nations face costly ramp up of cold-chain infrastructure
BioNTech gets $445 million in German funding for vaccine. Bloomberg.com. 15. rujna 2020. Inačica izvorne stranice arhivirana 9. studenoga 2020. Pristupljeno 10. studenoga 2020.
Mexico Approves Pfizer Vaccine for Emergency Use as Covid Surges. Bloomberg. 12. prosinca 2020. Pristupljeno 12. prosinca 2020.
Saudi Arabia to Launch Its Coronavirus Vaccination Program (španjolski). Boomberg. Pristupljeno 17. prosinca 2020.
Pfizer Has Offered South Africa Discounted Covid-19 Vaccines. Bloomberg.com (engleski). 4. siječnja 2021. Pristupljeno 5. siječnja 2021.

canada.ca

covid-vaccine.canada.ca

Regulatory Decision Summary - Pfizer-BioNTech COVID-19 Vaccine. Health Canada. 9. prosinca 2020. Inačica izvorne stranice arhivirana 9. prosinca 2020. Pristupljeno 9. prosinca 2020.
Pfizer-BioNTech COVID-19 Vaccine (tozinameran). Health Canada. Pristupljeno 15. prosinca 2020.

canada.ca

Drug and vaccine authorizations for COVID-19: List of applications received. Health Canada. 9. prosinca 2020. Pristupljeno 9. prosinca 2020.

cbc.ca

Tasker JP. 9. studenoga 2020. Trudeau says promising new Pfizer vaccine could be 'light at the end of the tunnel'. CBC News. Inačica izvorne stranice arhivirana 9. studenoga 2020. Pristupljeno 9. studenoga 2020.

cdc.gov

Oliver SE, Gargano JW, Marin M, Wallace M, Curran KG, Chamberland M, McClung N, Campos-Outcalt D, Morgan RL, Mbaeyi S, Romero JR, Talbot HK, Lee GM, Bell BP, Dooling K. Prosinac 2020. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020 (PDF). MMWR. 69 (50): 1922–24. doi:10.15585/mmwr.mm6950e2. PMID 33332292
COVID-19 and Your Health. Centers for Disease Control and Prevention (CDC). 19. prosinca 2020. Pristupljeno 22. prosinca 2020.
Management of Anaphylaxis at COVID-19 Vaccination Sites. Centers for Disease Control and Prevention (CDC). Pristupljeno 22. prosinca 2020.

cnn.com

Pleitgen F. 11. studenoga 2020. EU agrees to buy 300 million doses of the Pfizer/BioNTech Covid-19 vaccine. CNN. Inačica izvorne stranice arhivirana 24. studenoga 2020. Pristupljeno 26. studenoga 2020.

cvdvaccine-us.com

Questions and Answers About Pfizer-BioNTech COVID-19 Vaccine. Pfizer. Inačica izvorne stranice arhivirana 24. siječnja 2021. Pristupljeno 16. prosinca 2020.
Pfizer-BioNTech COVID-19 Vaccine Vaccination Storage & Dry Ice Safety Handling. Pfizer. Inačica izvorne stranice arhivirana 24. siječnja 2021. Pristupljeno 17. prosinca 2020.

degruyter.com

Bohn, Mary Kathryn. 7. listopada 2020. IFCC Interim Guidelines on Molecular Testing of SARS-CoV-2 Infection. Clinical Chemistry and Laboratory Medicine. 58: 1993–2000. doi:10.1515/cclm-2020-1412

doi.org

Walsh EE, Frenck RW, Falsey AR, Kitchin N, Absalon J, Gurtman A, Lockhart S, Neuzil K, Mulligan MJ, Bailey R, Swanson KA, Li P, Koury K, Kalina W, Cooper D, Fontes-Garfias C, Shi PY, Türeci Ö, Tompkins KR, Lyke KE, Raabe V, Dormitzer PR, Jansen KU, Şahin U, Gruber WC. Listopad 2020. Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates. The New England Journal of Medicine. 383 (25): 2439–50. doi:10.1056/NEJMoa2027906. PMC 7583697. PMID 33053279
Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Pérez Marc G, Moreira ED, Zerbini C, Bailey R, Swanson KA, Roychoudhury S, Koury K, Li P, Kalina WV, Cooper D, Frenck RW, Hammitt LL, Türeci Ö, Nell H, Schaefer A, Ünal S, Tresnan DB, Mather S, Dormitzer PR, Şahin U, Jansen KU, Gruber WC. Prosinac 2020. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. doi:10.1056/NEJMoa2034577. PMC 7745181. PMID 33301246
Polack, Fernando. 10. prosinca 2020. Safety and Efficacy of the mRNA Covid-19 Vaccine. New England Journal of Medicine. doi:10.1056/NEJMoa2034577. development of BNT162b2 was initiated on January 10, 2020, when the SARS-CoV-2 genetic sequence was released by the Chinese Center for Disease Control and Prevention and disseminated globally by the GISAID (Global Initiative on Sharing All Influenza Data) initiative
Bohn, Mary Kathryn. 7. listopada 2020. IFCC Interim Guidelines on Molecular Testing of SARS-CoV-2 Infection. Clinical Chemistry and Laboratory Medicine. 58: 1993–2000. doi:10.1515/cclm-2020-1412
Thanh Le T, Andreadakis Z, Kumar A, Gómez Román R, Tollefsen S, Saville M, Mayhew S. 9. travnja 2020. The COVID-19 vaccine development landscape. Nature Reviews Drug Discovery. 19 (5): 305–06. doi:10.1038/d41573-020-00073-5. ISSN 1474-1776. PMID 32273591
Fauci AS, Lane HC, Redfield RR. Ožujak 2020. Covid-19: Navigating the uncharted. The New England Journal of Medicine. 382 (13): 1268–69. doi:10.1056/nejme2002387. PMC 7121221. PMID 32109011
Mulligan MJ, Lyke KE, Kitchin N, Absalon J, Gurtman A, Lockhart S, Neuzil K, Raabe V, Bailey R, Swanson KA, Li P, Koury K, Kalina W, Cooper D, Fontes-Garfias C, Shi PY, Türeci Ö, Tompkins KR, Walsh EE, Frenck R, Falsey AR, Dormitzer PR, Gruber WC, Şahin U, Jansen KU. Listopad 2020. Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults. Nature. 586 (7830): 589–593. doi:10.1038/s41586-020-2639-4. PMID 32785213. S2CID 221126922
Gaebler C, Nussenzweig MC. Listopad 2020. All eyes on a hurdle race for a SARS-CoV-2 vaccine. Nature. 586 (7830): 501–2. doi:10.1038/d41586-020-02926-w. PMID 33077943. S2CID 224808629
Pallesen J, Wang N, Corbett KS, Wrapp D, Kirchdoerfer RN, Turner HL, Cottrell CA, Becker MM, Wang L, Shi W, Kong WP, Andres EL, Kettenbach AN, Denison MR, Chappell JD, Graham BS, Ward AB, McLellan JS. Kolovoz 2017. Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen. Proceedings of the National Academy of Sciences of the United States of America. 114 (35): E7348–E7357. doi:10.1073/pnas.1707304114. PMC 5584442. PMID 28807998
Orlandini von Niessen AG, Poleganov MA, Rechner C, Plaschke A, Kranz LM, Fesser S, Diken M, Löwer M, Vallazza B, Beissert T, Bukur V, Kuhn AN, Türeci Ö, Sahin U. Travanj 2019. Improving mRNA-Based Therapeutic Gene Delivery by Expression-Augmenting 3' UTRs Identified by Cellular Library Screening. Molecular Therapy. 27 (4). doi:10.1016/j.ymthe.2018.12.011. PMC 6453560. PMID 30638957
Oliver SE, Gargano JW, Marin M, Wallace M, Curran KG, Chamberland M, McClung N, Campos-Outcalt D, Morgan RL, Mbaeyi S, Romero JR, Talbot HK, Lee GM, Bell BP, Dooling K. Prosinac 2020. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020 (PDF). MMWR. 69 (50): 1922–24. doi:10.15585/mmwr.mm6950e2. PMID 33332292
Cabanillas B, Akdis C, Novak N. 2020. Allergic reactions to the first COVID‐19 vaccine: A potential role of Polyethylene glycol?. Allergy. doi:10.1111/all.14711. PMID 33320974. S2CID 229284320

eib.org

Germany: Investment Plan for Europe – EIB to provide BioNTech with up to €100 million in debt financing for COVID-19 vaccine development and manufacturing. European Investment Bank. 11. lipnja 2020. Inačica izvorne stranice arhivirana 9. studenoga 2020. Pristupljeno 10. studenoga 2020.

elpais.com

Chile y Ecuador se adelantan en Sudamérica y autorizan la vacuna de Pfizer. El Pais. Pristupljeno 17. prosinca 2020.

emirateswoman.com

Dubai approves the Pfizer-BioNTech vaccine which will be free of charge. Emirates Woman. 23. prosinca 2020. Pristupljeno 28. prosinca 2020.

england.nhs.uk

COVID-19 Vaccination Statistics –Week ending Sunday 20th December 2020 (PDF). NHS. 24. prosinca 2020.

europa.eu

ema.europa.eu

EMA Assessment Report (PDF). www.ema.europa.eu. 21. prosinca 2020. Pristupljeno 29. prosinca 2020.
EMA recommends first COVID-19 vaccine for authorisation in the EU. European Medicines Agency (EMA) (priopćenje). 21. prosinca 2020. Pristupljeno 21. prosinca 2020.
Comirnaty EPAR. European Medicines Agency (EMA). Pristupljeno 23. prosinca 2020.

ec.europa.eu

Statement by President von der Leyen on the marketing authorisation of the BioNTech-Pfizer vaccine against COVID-19. European Commission. Pristupljeno 21. prosinca 2020.

europeanpharmaceuticalreview.com

Hannah B. 7. listopada 2020. EMA begins rolling review of BNT162b2 COVID-19 vaccine. European Pharmaceutical Review. Inačica izvorne stranice arhivirana 11. studenoga 2020. Pristupljeno 11. studenoga 2020.

fda.gov

Emergency Use Authorization for vaccines explained. U.S. Food and Drug Administration (FDA). 20. studenoga 2020. Inačica izvorne stranice arhivirana 20. studenoga 2020. Pristupljeno 20. studenoga 2020. Ovaj članak sadrži tekst iz ovog izvora, koji je u javnom vlasništvu.
Pfizer-BioNTech COVID-19 Vaccine EUA Letter of Authorization (PDF). U.S. Food and Drug Administration (FDA). 11. prosinca 2020. Ovaj članak sadrži tekst iz ovog izvora, koji je u javnom vlasništvu.
Pfizer-BioNTech COVID-19 Vaccine EUA Fact Sheet for Healthcare Providers (PDF). Pfizer. 11. prosinca 2020.
Pfizer-BioNTech COVID-19 Vaccine Frequently Asked Questions. U.S. Food and Drug Administration. 11. prosinca 2020. Pristupljeno 29. prosinca 2020. Ovaj članak sadrži tekst iz ovog izvora, koji je u javnom vlasništvu.

fortune.com

How China's COVID-19 could fill the gaps left by Pfizer, Moderna, AstraZeneca. Fortune. 5. prosinca 2020. Inačica izvorne stranice arhivirana 12. prosinca 2020. Pristupljeno 5. prosinca 2020.

france24.com

Jordan approves Pfizer-BioNTech Covid vaccine. France 24. 15. prosinca 2020. Pristupljeno 15. prosinca 2020.

gatesnotes.com

Gates B. 30. travnja 2020. The vaccine race explained: What you need to know about the COVID-19 vaccine. The Gates Notes. Inačica izvorne stranice arhivirana 14. svibnja 2020. Pristupljeno 2. svibnja 2020.

gob.mx

Salud Sd. 233. Firma secretario de Salud convenio con Pfizer para fabricación y suministro de vacuna COVID-19. gob.mx (španjolski). Pristupljeno 17. prosinca 2020.

gov.uk

UK medicines regulator gives approval for first UK COVID-19 vaccine (priopćenje). Medicines and Healthcare products Regulatory Agency (MHRA). 2. prosinca 2020. Pristupljeno 2. prosinca 2020.
Regulatory approval of Pfizer / BioNTech vaccine for COVID-19. Medicines and Healthcare products Regulatory Agency (MHRA). 2. prosinca 2020. Pristupljeno 2. prosinca 2020.
UK medicines regulator gives approval for first UK COVID-19 vaccine. Medicines and Healthcare products Regulatory Agency (MHRA). 2. prosinca 2020. Inačica izvorne stranice arhivirana 2. prosinca 2020. Pristupljeno 2. prosinca 2020.

gponline.com

Bostock N. 9. prosinca 2020. MHRA warning after allergic reactions in NHS staff given COVID-19 vaccine. GP. Inačica izvorne stranice arhivirana 9. prosinca 2020. Pristupljeno 9. prosinca 2020.

gulfnews.com

Yasmena Al Mulla. 13. prosinca 2020. Kuwait approves emergency use of Pfizer vaccine. Gulf News. Pristupljeno 14. prosinca 2020.

healthycanadians.gc.ca

Pfizer-BioNTech COVID-19 vaccine: Health Canada recommendations for people with serious allergies. Health Canada. 12. prosinca 2020.

heidi.news

Pralong, Julien. 23. prosinca 2020. La piqûre de l'espoir pratiquée à Lucerne. Heidi.news. Pristupljeno 23. prosinca 2020.

hhs.gov

U.S. Government Engages Pfizer to Produce Millions of Doses of COVID-19 Vaccine. US Department of Health and Human Services. 22. srpnja 2020. Inačica izvorne stranice arhivirana 22. srpnja 2020. Pristupljeno 23. srpnja 2020.

jakartaglobe.id

Pfizer's Vaccine Is Out of the Question as Indonesia Lacks Refrigerators: State Pharma Boss. Jakarta Globe. 22. studenoga 2020. Inačica izvorne stranice arhivirana 7. prosinca 2020. Pristupljeno 5. prosinca 2020.

japantimes.co.jp

Japan and Pfizer reach COVID-19 vaccine deal to treat 60 million people. The Japan Times. 1. kolovoza 2020. Inačica izvorne stranice arhivirana 10. studenoga 2020. Pristupljeno 21. studenoga 2020.

jpost.com

Israeli Health Minister 'pleased' as FDA approves Pfizer COVID-19 vaccine. The Jerusalem Post. Pristupljeno 28. prosinca 2020.

lanacion.com.ar

Coronavirus en la Argentina: La ANMAT aprobo el uso de emergencia de la vacuna Pfizer. La Nación (španjolski). Pristupljeno 25. prosinca 2020.

letemps.ch

Swissmedic autorise un premier vaccin contre le coronavirus (francuski). Le Temps. 19. prosinca 2020. Pristupljeno 19. prosinca 2020.

luzernerzeitung.ch

Erni, Salome. 23. prosinca 2020. 90-jährige Luzernerin als erste Person in der Schweiz gegen Corona geimpft. Luzerner Zeitung. Pristupljeno 23. prosinca 2020.

mednet-communities.net

World Health Organization. INN: Tozinameran. WHO MedNet. Inačica izvorne stranice arhivirana 9. ožujka 2021. Pristupljeno 1. prosinca 2020.
World Health Organization. Messenger RNA encoding the full-length SARS-CoV-2 spike glycoprotein. WHO MedNet. Inačica izvorne stranice (DOC) arhivirana 5. siječnja 2021. Pristupljeno 16. prosinca 2020.

msn.com

Iraq grants emergency approval for Pfizer COVID-19 vaccine. MSN. Pristupljeno 27. prosinca 2020.

nbcnews.com

Edwards E. 9. studenoga 2020. Pfizer's Covid-19 vaccine promising, but many questions remain. NBC News. Inačica izvorne stranice arhivirana 22. studenoga 2020. Pristupljeno 12. studenoga 2020.

nejm.org

Polack, Fernando. 10. prosinca 2020. Safety and Efficacy of the mRNA Covid-19 Vaccine. New England Journal of Medicine. doi:10.1056/NEJMoa2034577. development of BNT162b2 was initiated on January 10, 2020, when the SARS-CoV-2 genetic sequence was released by the Chinese Center for Disease Control and Prevention and disseminated globally by the GISAID (Global Initiative on Sharing All Influenza Data) initiative

newsd.in

WHO clears Pfizer-BioNTech coronavirus vaccine for emergency use. Newsd.in. 1. siječnja 2021. Pristupljeno 1. siječnja 2021.

nhs.uk

Coronavirus vaccine. National Health Service. 7. prosinca 2020. Inačica izvorne stranice arhivirana 7. prosinca 2020. Pristupljeno 7. prosinca 2020.

nice.org.uk

bnf.nice.org.uk

Adverse reactions to drugs. British National Formulary. Pristupljeno 19. prosinca 2020.

nih.gov

pubmed.ncbi.nlm.nih.gov

Walsh EE, Frenck RW, Falsey AR, Kitchin N, Absalon J, Gurtman A, Lockhart S, Neuzil K, Mulligan MJ, Bailey R, Swanson KA, Li P, Koury K, Kalina W, Cooper D, Fontes-Garfias C, Shi PY, Türeci Ö, Tompkins KR, Lyke KE, Raabe V, Dormitzer PR, Jansen KU, Şahin U, Gruber WC. Listopad 2020. Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates. The New England Journal of Medicine. 383 (25): 2439–50. doi:10.1056/NEJMoa2027906. PMC 7583697. PMID 33053279
Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Pérez Marc G, Moreira ED, Zerbini C, Bailey R, Swanson KA, Roychoudhury S, Koury K, Li P, Kalina WV, Cooper D, Frenck RW, Hammitt LL, Türeci Ö, Nell H, Schaefer A, Ünal S, Tresnan DB, Mather S, Dormitzer PR, Şahin U, Jansen KU, Gruber WC. Prosinac 2020. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. doi:10.1056/NEJMoa2034577. PMC 7745181. PMID 33301246
Thanh Le T, Andreadakis Z, Kumar A, Gómez Román R, Tollefsen S, Saville M, Mayhew S. 9. travnja 2020. The COVID-19 vaccine development landscape. Nature Reviews Drug Discovery. 19 (5): 305–06. doi:10.1038/d41573-020-00073-5. ISSN 1474-1776. PMID 32273591
Fauci AS, Lane HC, Redfield RR. Ožujak 2020. Covid-19: Navigating the uncharted. The New England Journal of Medicine. 382 (13): 1268–69. doi:10.1056/nejme2002387. PMC 7121221. PMID 32109011
Mulligan MJ, Lyke KE, Kitchin N, Absalon J, Gurtman A, Lockhart S, Neuzil K, Raabe V, Bailey R, Swanson KA, Li P, Koury K, Kalina W, Cooper D, Fontes-Garfias C, Shi PY, Türeci Ö, Tompkins KR, Walsh EE, Frenck R, Falsey AR, Dormitzer PR, Gruber WC, Şahin U, Jansen KU. Listopad 2020. Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults. Nature. 586 (7830): 589–593. doi:10.1038/s41586-020-2639-4. PMID 32785213. S2CID 221126922
Gaebler C, Nussenzweig MC. Listopad 2020. All eyes on a hurdle race for a SARS-CoV-2 vaccine. Nature. 586 (7830): 501–2. doi:10.1038/d41586-020-02926-w. PMID 33077943. S2CID 224808629
Pallesen J, Wang N, Corbett KS, Wrapp D, Kirchdoerfer RN, Turner HL, Cottrell CA, Becker MM, Wang L, Shi W, Kong WP, Andres EL, Kettenbach AN, Denison MR, Chappell JD, Graham BS, Ward AB, McLellan JS. Kolovoz 2017. Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen. Proceedings of the National Academy of Sciences of the United States of America. 114 (35): E7348–E7357. doi:10.1073/pnas.1707304114. PMC 5584442. PMID 28807998
Orlandini von Niessen AG, Poleganov MA, Rechner C, Plaschke A, Kranz LM, Fesser S, Diken M, Löwer M, Vallazza B, Beissert T, Bukur V, Kuhn AN, Türeci Ö, Sahin U. Travanj 2019. Improving mRNA-Based Therapeutic Gene Delivery by Expression-Augmenting 3' UTRs Identified by Cellular Library Screening. Molecular Therapy. 27 (4). doi:10.1016/j.ymthe.2018.12.011. PMC 6453560. PMID 30638957
Oliver SE, Gargano JW, Marin M, Wallace M, Curran KG, Chamberland M, McClung N, Campos-Outcalt D, Morgan RL, Mbaeyi S, Romero JR, Talbot HK, Lee GM, Bell BP, Dooling K. Prosinac 2020. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020 (PDF). MMWR. 69 (50): 1922–24. doi:10.15585/mmwr.mm6950e2. PMID 33332292
Cabanillas B, Akdis C, Novak N. 2020. Allergic reactions to the first COVID‐19 vaccine: A potential role of Polyethylene glycol?. Allergy. doi:10.1111/all.14711. PMID 33320974. S2CID 229284320

ncbi.nlm.nih.gov

Walsh EE, Frenck RW, Falsey AR, Kitchin N, Absalon J, Gurtman A, Lockhart S, Neuzil K, Mulligan MJ, Bailey R, Swanson KA, Li P, Koury K, Kalina W, Cooper D, Fontes-Garfias C, Shi PY, Türeci Ö, Tompkins KR, Lyke KE, Raabe V, Dormitzer PR, Jansen KU, Şahin U, Gruber WC. Listopad 2020. Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates. The New England Journal of Medicine. 383 (25): 2439–50. doi:10.1056/NEJMoa2027906. PMC 7583697. PMID 33053279
Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Pérez Marc G, Moreira ED, Zerbini C, Bailey R, Swanson KA, Roychoudhury S, Koury K, Li P, Kalina WV, Cooper D, Frenck RW, Hammitt LL, Türeci Ö, Nell H, Schaefer A, Ünal S, Tresnan DB, Mather S, Dormitzer PR, Şahin U, Jansen KU, Gruber WC. Prosinac 2020. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. doi:10.1056/NEJMoa2034577. PMC 7745181. PMID 33301246
Fauci AS, Lane HC, Redfield RR. Ožujak 2020. Covid-19: Navigating the uncharted. The New England Journal of Medicine. 382 (13): 1268–69. doi:10.1056/nejme2002387. PMC 7121221. PMID 32109011
Pallesen J, Wang N, Corbett KS, Wrapp D, Kirchdoerfer RN, Turner HL, Cottrell CA, Becker MM, Wang L, Shi W, Kong WP, Andres EL, Kettenbach AN, Denison MR, Chappell JD, Graham BS, Ward AB, McLellan JS. Kolovoz 2017. Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen. Proceedings of the National Academy of Sciences of the United States of America. 114 (35): E7348–E7357. doi:10.1073/pnas.1707304114. PMC 5584442. PMID 28807998
Orlandini von Niessen AG, Poleganov MA, Rechner C, Plaschke A, Kranz LM, Fesser S, Diken M, Löwer M, Vallazza B, Beissert T, Bukur V, Kuhn AN, Türeci Ö, Sahin U. Travanj 2019. Improving mRNA-Based Therapeutic Gene Delivery by Expression-Augmenting 3' UTRs Identified by Cellular Library Screening. Molecular Therapy. 27 (4). doi:10.1016/j.ymthe.2018.12.011. PMC 6453560. PMID 30638957

npr.org

Palca J. 9. studenoga 2020. Pfizer says experimental COVID-19 vaccine is more than 90% effective. NPR. Inačica izvorne stranice arhivirana 9. studenoga 2020. Pristupljeno 9. studenoga 2020.

nytimes.com

Mueller B. 2. prosinca 2020. U.K. Approves Pfizer Coronavirus Vaccine, a First in the West. The New York Times. Pristupljeno 2. prosinca 2020.
Thomas K, Gelles D, Zimmer C. 9. studenoga 2020. Pfizer's early data shows vaccine is more than 90% effective. The New York Times. Inačica izvorne stranice arhivirana 23. studenoga 2020. Pristupljeno 9. studenoga 2020.

reuters.com

Burger L. 15. ožujka 2020. BioNTech in China alliance with Fosun over coronavirus vaccine candidate. Reuters. Inačica izvorne stranice arhivirana 14. studenoga 2020. Pristupljeno 10. studenoga 2020.
China's Fosun to end BioNTech's COVID-19 vaccine trial, seek approval for another. Reuters. 3. studenoga 2020. Inačica izvorne stranice arhivirana 12. prosinca 2020. Pristupljeno 21. studenoga 2020.
Reuters Staff. 23. prosinca 2020. First Pfizer COVID-19 vaccines set to reach Costa Rica on Wednesday - president. Reuters (engleski). Pristupljeno 24. prosinca 2020.
Oman issues licence to import Pfizer BioNTech Covid vaccine - TV. Reuters. 15. prosinca 2020. Pristupljeno 16. prosinca 2020.
Qatar, Oman to receive Pfizer-BioNTech COVID-19 vaccine this week. Reuters. Pristupljeno 24. prosinca 2020.
Erman M, Ankur B. 22. srpnja 2020. U.S. to pay Pfizer, BioNTech $1.95 bln for millions of COVID-19 vaccine doses. Reuters. Inačica izvorne stranice arhivirana 22. srpnja 2020. Pristupljeno 22. srpnja 2020.

scmp.com

Ng E. 27. kolovoza 2020. Fosun Pharma to supply Covid-19 vaccine to Hong Kong, Macau once approved. South China Morning Post. Inačica izvorne stranice arhivirana 20. studenoga 2020. Pristupljeno 21. studenoga 2020.
Ting V, Lau C, Wong O. 11. prosinca 2020. Hong Kong buys 15 million Covid-19 vaccine doses from Sinovac, Pfizer. South China Morning Post. Pristupljeno 18. prosinca 2020.

semanticscholar.org

api.semanticscholar.org

Mulligan MJ, Lyke KE, Kitchin N, Absalon J, Gurtman A, Lockhart S, Neuzil K, Raabe V, Bailey R, Swanson KA, Li P, Koury K, Kalina W, Cooper D, Fontes-Garfias C, Shi PY, Türeci Ö, Tompkins KR, Walsh EE, Frenck R, Falsey AR, Dormitzer PR, Gruber WC, Şahin U, Jansen KU. Listopad 2020. Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults. Nature. 586 (7830): 589–593. doi:10.1038/s41586-020-2639-4. PMID 32785213. S2CID 221126922
Gaebler C, Nussenzweig MC. Listopad 2020. All eyes on a hurdle race for a SARS-CoV-2 vaccine. Nature. 586 (7830): 501–2. doi:10.1038/d41586-020-02926-w. PMID 33077943. S2CID 224808629
Cabanillas B, Akdis C, Novak N. 2020. Allergic reactions to the first COVID‐19 vaccine: A potential role of Polyethylene glycol?. Allergy. doi:10.1111/all.14711. PMID 33320974. S2CID 229284320

statnews.com

Herper M. 9. studenoga 2020. Covid-19 vaccine from Pfizer and BioNTech is strongly effective, early data from large trial indicate. STAT. Inačica izvorne stranice arhivirana 9. studenoga 2020. Pristupljeno 9. studenoga 2020.

swr.de

Papadopoulos C. 14. prosinca 2020. Chronologie - So entstand der Corona-Impfstoff von Biontech [Chronology - That's how the Covid-vaccine of Biontech was being developed] (njemački). Südwestrundfunk. Inačica izvorne stranice arhivirana 2. prosinca 2020. Pristupljeno 20. prosinca 2020.

telegraph.co.uk

Newey S. 8. rujna 2020. Daunting task of distribution exposed as it emerges some vaccines must be 'deep frozen' at −70C. The Telegraph. Inačica izvorne stranice arhivirana 9. studenoga 2020. Pristupljeno 10. studenoga 2020.

theglobeandmail.com

Furtula A, Jordans F. 21. prosinca 2020. EU regulator gives conditional approval to Pfizer-BioNTech COVID-19 vaccine. The Globe and Mail Inc. Reuters

theguardian.com

Boseley S, Halliday J. 2. prosinca 2020. UK approves Pfizer/BioNTech Covid vaccine for rollout next week. The Guardian. Pristupljeno 14. prosinca 2020.
Henley J, Connolly K, Jones S. 3. prosinca 2020. European and US experts question UK's fast-track of Covid vaccine. The Guardian. Inačica izvorne stranice arhivirana 9. prosinca 2020. Pristupljeno 9. prosinca 2020.
Kollewe J. Pfizer and BioNTech's vaccine poses global logistics challenge. The Guardian. Inačica izvorne stranice arhivirana 10. studenoga 2020. Pristupljeno 10. studenoga 2020.

washingtonpost.com

Sun LH, Stanley-Becker I. CDC greenlights advisory group's decision to recommend Pfizer vaccine for use. The Washington Post. Pristupljeno 14. prosinca 2020.
Booth W, Cunningham E. 9. prosinca 2020. Britain warns against Pfizer vaccine for people with history of 'significant' allergic reactions. The Washington Post. Inačica izvorne stranice arhivirana 9. prosinca 2020. Pristupljeno 9. prosinca 2020.
Johnson CY. 17. studenoga 2020. A vial, a vaccine and hopes for slowing a pandemic — how a shot comes to be. The Washington Post. Pristupljeno 21. prosinca 2020.

web.archive.org

World Health Organization. 2020. International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 124 – COVID-19 (special edition) (PDF). WHO Drug Information. 34 (3): 666. Inačica izvorne stranice arhivirana (PDF) 27. studenoga 2020. Pristupljeno 23. studenoga 2020.
Pfizer and BioNTech Celebrate Historic First Authorization in the U.S. of Vaccine to Prevent COVID-19. Pfizer Inc. and BioNTech SE. Inačica izvorne stranice arhivirana 28. ožujka 2021. Pristupljeno 5. siječnja 2021.
Palca J. 9. studenoga 2020. Pfizer says experimental COVID-19 vaccine is more than 90% effective. NPR. Inačica izvorne stranice arhivirana 9. studenoga 2020. Pristupljeno 9. studenoga 2020.
Herper M. 9. studenoga 2020. Covid-19 vaccine from Pfizer and BioNTech is strongly effective, early data from large trial indicate. STAT. Inačica izvorne stranice arhivirana 9. studenoga 2020. Pristupljeno 9. studenoga 2020.
Edwards E. 9. studenoga 2020. Pfizer's Covid-19 vaccine promising, but many questions remain. NBC News. Inačica izvorne stranice arhivirana 22. studenoga 2020. Pristupljeno 12. studenoga 2020.
Gallagher J. 9. studenoga 2020. Covid vaccine: First 'milestone' vaccine offers 90% protection. BBC News. Inačica izvorne stranice arhivirana 26. studenoga 2020. Pristupljeno 9. studenoga 2020.
Update on our COVID-19 vaccine development program with BNT162b2 (priopćenje). BioNTech. 2. prosinca 2020. Inačica izvorne stranice (PDF) arhivirana 3. prosinca 2020. Pristupljeno 12. prosinca 2020.
Questions and Answers About Pfizer-BioNTech COVID-19 Vaccine. Pfizer. Inačica izvorne stranice arhivirana 24. siječnja 2021. Pristupljeno 16. prosinca 2020.
Coronavirus vaccine. National Health Service. 7. prosinca 2020. Inačica izvorne stranice arhivirana 7. prosinca 2020. Pristupljeno 7. prosinca 2020.
Regulatory Decision Summary - Pfizer-BioNTech COVID-19 Vaccine. Health Canada. 9. prosinca 2020. Inačica izvorne stranice arhivirana 9. prosinca 2020. Pristupljeno 9. prosinca 2020.
Bahrain becomes second country to approve Pfizer COVID-19 vaccine. Al Jazeera. Inačica izvorne stranice arhivirana 4. prosinca 2020. Pristupljeno 5. prosinca 2020.
- Coronavirus: Saudi Arabia approves Pfizer COVID-19 vaccine for use. Al Arabiya English. 10. prosinca 2020. Inačica izvorne stranice arhivirana 11. prosinca 2020. Pristupljeno 10. prosinca 2020.
- Deep-freeze hurdle makes Pfizer's vaccine one for the rich. Bloomberg. 10. studenoga 2020. Inačica izvorne stranice arhivirana 22. studenoga 2020. Pristupljeno 12. studenoga 2020.. Vaccine goes bad five days after thawing, requires two shots; Many nations face costly ramp up of cold-chain infrastructure
- Pfizer-BioNTech COVID-19 Vaccine Vaccination Storage & Dry Ice Safety Handling. Pfizer. Inačica izvorne stranice arhivirana 24. siječnja 2021. Pristupljeno 17. prosinca 2020.
- Gates B. 30. travnja 2020. The vaccine race explained: What you need to know about the COVID-19 vaccine. The Gates Notes. Inačica izvorne stranice arhivirana 14. svibnja 2020. Pristupljeno 2. svibnja 2020.
- World Health Organization timeline – COVID-19. World Health Organization. 27. travnja 2020. Inačica izvorne stranice arhivirana 29. travnja 2020. Pristupljeno 2. svibnja 2020.
- Papadopoulos C. 14. prosinca 2020. Chronologie - So entstand der Corona-Impfstoff von Biontech [Chronology - That's how the Covid-vaccine of Biontech was being developed] (njemački). Südwestrundfunk. Inačica izvorne stranice arhivirana 2. prosinca 2020. Pristupljeno 20. prosinca 2020.
- Burger L. 15. ožujka 2020. BioNTech in China alliance with Fosun over coronavirus vaccine candidate. Reuters. Inačica izvorne stranice arhivirana 14. studenoga 2020. Pristupljeno 10. studenoga 2020.
- BioNTech gets $445 million in German funding for vaccine. Bloomberg.com. 15. rujna 2020. Inačica izvorne stranice arhivirana 9. studenoga 2020. Pristupljeno 10. studenoga 2020.
- Germany: Investment Plan for Europe – EIB to provide BioNTech with up to €100 million in debt financing for COVID-19 vaccine development and manufacturing. European Investment Bank. 11. lipnja 2020. Inačica izvorne stranice arhivirana 9. studenoga 2020. Pristupljeno 10. studenoga 2020.
- Pfizer CEO says he would've released vaccine data before election if possible. Axios. 9. studenoga 2020. Inačica izvorne stranice arhivirana 10. studenoga 2020. Pristupljeno 11. studenoga 2020.
- Hannah B. 7. listopada 2020. EMA begins rolling review of BNT162b2 COVID-19 vaccine. European Pharmaceutical Review. Inačica izvorne stranice arhivirana 11. studenoga 2020. Pristupljeno 11. studenoga 2020.
- China's Fosun to end BioNTech's COVID-19 vaccine trial, seek approval for another. Reuters. 3. studenoga 2020. Inačica izvorne stranice arhivirana 12. prosinca 2020. Pristupljeno 21. studenoga 2020.
- World Health Organization. INN: Tozinameran. WHO MedNet. Inačica izvorne stranice arhivirana 9. ožujka 2021. Pristupljeno 1. prosinca 2020.
- World Health Organization. Messenger RNA encoding the full-length SARS-CoV-2 spike glycoprotein. WHO MedNet. Inačica izvorne stranice (DOC) arhivirana 5. siječnja 2021. Pristupljeno 16. prosinca 2020.
- UK medicines regulator gives approval for first UK COVID-19 vaccine. Medicines and Healthcare products Regulatory Agency (MHRA). 2. prosinca 2020. Inačica izvorne stranice arhivirana 2. prosinca 2020. Pristupljeno 2. prosinca 2020.
- Neergaard L, Kirka D. 2. prosinca 2020. Britain OKs Pfizer vaccine and will begin shots within days. AP. Inačica izvorne stranice arhivirana 6. prosinca 2020. Pristupljeno 6. prosinca 2020.
- Roberts M. 2. prosinca 2020. Covid Pfizer vaccine approved for use next week in UK. BBC News Online. Inačica izvorne stranice arhivirana 2. prosinca 2020. Pristupljeno 2. prosinca 2020.
- Henley J, Connolly K, Jones S. 3. prosinca 2020. European and US experts question UK's fast-track of Covid vaccine. The Guardian. Inačica izvorne stranice arhivirana 9. prosinca 2020. Pristupljeno 9. prosinca 2020.
- First patient receives Pfizer Covid-19 vaccine. 8. prosinca 2020. Inačica izvorne stranice arhivirana 8. prosinca 2020. Pristupljeno 8. prosinca 2020. Prenosi www.bbc.co.uk
- Emergency Use Authorization for vaccines explained. U.S. Food and Drug Administration (FDA). 20. studenoga 2020. Inačica izvorne stranice arhivirana 20. studenoga 2020. Pristupljeno 20. studenoga 2020. Ovaj članak sadrži tekst iz ovog izvora, koji je u javnom vlasništvu.
- Bostock N. 9. prosinca 2020. MHRA warning after allergic reactions in NHS staff given COVID-19 vaccine. GP. Inačica izvorne stranice arhivirana 9. prosinca 2020. Pristupljeno 9. prosinca 2020.
- Booth W, Cunningham E. 9. prosinca 2020. Britain warns against Pfizer vaccine for people with history of 'significant' allergic reactions. The Washington Post. Inačica izvorne stranice arhivirana 9. prosinca 2020. Pristupljeno 9. prosinca 2020.
- Thomas K, Gelles D, Zimmer C. 9. studenoga 2020. Pfizer's early data shows vaccine is more than 90% effective. The New York Times. Inačica izvorne stranice arhivirana 23. studenoga 2020. Pristupljeno 9. studenoga 2020.
- Erman M, Ankur B. 22. srpnja 2020. U.S. to pay Pfizer, BioNTech $1.95 bln for millions of COVID-19 vaccine doses. Reuters. Inačica izvorne stranice arhivirana 22. srpnja 2020. Pristupljeno 22. srpnja 2020.
- U.S. Government Engages Pfizer to Produce Millions of Doses of COVID-19 Vaccine. US Department of Health and Human Services. 22. srpnja 2020. Inačica izvorne stranice arhivirana 22. srpnja 2020. Pristupljeno 23. srpnja 2020.
- Nazaryan A. 9. studenoga 2020. So is Pfizer part of Operation Warp Speed or not? Yes and no. Yahoo!. Inačica izvorne stranice arhivirana 10. studenoga 2020. Pristupljeno 9. studenoga 2020.
- Pleitgen F. 11. studenoga 2020. EU agrees to buy 300 million doses of the Pfizer/BioNTech Covid-19 vaccine. CNN. Inačica izvorne stranice arhivirana 24. studenoga 2020. Pristupljeno 26. studenoga 2020.
- Japan and Pfizer reach COVID-19 vaccine deal to treat 60 million people. The Japan Times. 1. kolovoza 2020. Inačica izvorne stranice arhivirana 10. studenoga 2020. Pristupljeno 21. studenoga 2020.
- Tasker JP. 9. studenoga 2020. Trudeau says promising new Pfizer vaccine could be 'light at the end of the tunnel'. CBC News. Inačica izvorne stranice arhivirana 9. studenoga 2020. Pristupljeno 9. studenoga 2020.
- Ng E. 27. kolovoza 2020. Fosun Pharma to supply Covid-19 vaccine to Hong Kong, Macau once approved. South China Morning Post. Inačica izvorne stranice arhivirana 20. studenoga 2020. Pristupljeno 21. studenoga 2020.
- BioNTech and Fosun Pharma to Supply China with mRNA-based COVID-19 Vaccine (priopćenje). BioNTech. 16. prosinca 2020. Inačica izvorne stranice arhivirana 16. prosinca 2020. Pristupljeno 16. prosinca 2020.
- Kollewe J. Pfizer and BioNTech's vaccine poses global logistics challenge. The Guardian. Inačica izvorne stranice arhivirana 10. studenoga 2020. Pristupljeno 10. studenoga 2020.
- Newey S. 8. rujna 2020. Daunting task of distribution exposed as it emerges some vaccines must be 'deep frozen' at −70C. The Telegraph. Inačica izvorne stranice arhivirana 9. studenoga 2020. Pristupljeno 10. studenoga 2020.
- How China's COVID-19 could fill the gaps left by Pfizer, Moderna, AstraZeneca. Fortune. 5. prosinca 2020. Inačica izvorne stranice arhivirana 12. prosinca 2020. Pristupljeno 5. prosinca 2020.
- Pfizer's Vaccine Is Out of the Question as Indonesia Lacks Refrigerators: State Pharma Boss. Jakarta Globe. 22. studenoga 2020. Inačica izvorne stranice arhivirana 7. prosinca 2020. Pristupljeno 5. prosinca 2020.

who.int

World Health Organization. 2020. International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 124 – COVID-19 (special edition) (PDF). WHO Drug Information. 34 (3): 666. Inačica izvorne stranice arhivirana (PDF) 27. studenoga 2020. Pristupljeno 23. studenoga 2020.
World Health Organization timeline – COVID-19. World Health Organization. 27. travnja 2020. Inačica izvorne stranice arhivirana 29. travnja 2020. Pristupljeno 2. svibnja 2020.

wired.com

McKenna, Maryn. 17. prosinca 2020. Vaccines Are Here. We Have to Talk About Side Effects. Wired. Pristupljeno 23. prosinca 2020.

worldcat.org

Thanh Le T, Andreadakis Z, Kumar A, Gómez Román R, Tollefsen S, Saville M, Mayhew S. 9. travnja 2020. The COVID-19 vaccine development landscape. Nature Reviews Drug Discovery. 19 (5): 305–06. doi:10.1038/d41573-020-00073-5. ISSN 1474-1776. PMID 32273591

yahoo.com

finance.yahoo.com

Panama approves Pfizer's COVID-19 vaccine – health ministry. Yahoo! Finance. Pristupljeno 16. prosinca 2020.

news.yahoo.com

Nazaryan A. 9. studenoga 2020. So is Pfizer part of Operation Warp Speed or not? Yes and no. Yahoo!. Inačica izvorne stranice arhivirana 10. studenoga 2020. Pristupljeno 9. studenoga 2020.